 |
|
Social Phobia Symptoms, Subtypes, and Severity
Findings From a Community Survey
Murray B. Stein, MD;
Laine J. Torgrud, PhD;
John R. Walker, PhD
Arch Gen Psychiatry. 2000;57:1046-1052.
Objectives Our goals were (1) to ascertain the range of functional impairment attributable to social phobia in a community sample, and (2) to verify the existence of social phobia subtypes in the community, and report on their relative prevalence, severity, and levels of impairment.
Methods Community surveys were conducted contemporaneously in Winnipeg, Manitoba, and in Alberta, with a total of 1956 respondents. Instruments included the Comprehensive International Diagnostic Interview–Version 2.1 module for DSM-IV social phobia, enhanced with 6 additional (for a total of 12) social phobic situational probes to provide a more comprehensive assessment of possible subtypes, and additional questions about specific functional impairment due to social phobia.
Results Of those persons in the community surveyed, most had no (60.4%) or few (ie, 1-3) (27.8%) social fears; few persons (3.4%) had many (ie,  7). Among those with DSM-IV social phobia (7.2%), classification based on number (normally distributed with median of 3, mode of 5) or content (eg, speaking-only vs other fears; performance-only vs interactional fears) of social fears failed to yield a defensible subtyping solution. Impairment increased linearly as the number of social fears was increased, with no clear threshold evident.
Conclusions Social phobia is associated with substantial impairment in multiple functional domains. Support for subtyping based on the extent or pattern of social fears was not provided. Rather, social phobia in the community seems to exist on a continuum of severity, with a greater number of feared situations associated with greater disability.
From the Department of Psychiatry, University of California San Diego (Dr Stein); and the Departments of Psychiatry and Clinical Health Psychology, University of Manitoba, Winnipeg (Drs Torgrud and Walker).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Impact of Social Anxiety Disorder on Employment Among Women Receiving Welfare Benefits
Tolman et al.
Psychiatr. Serv. 2009;60:61-66.
ABSTRACT
| FULL TEXT
The Burden of Mental Disorders
Eaton et al.
Epidemiol Rev 2008;30:1-14.
ABSTRACT
| FULL TEXT
Augmentation of exposure therapy with d-cycloserine for social anxiety disorder.
Hofmann et al.
Arch Gen Psychiatry 2006;63:298-304.
ABSTRACT
| FULL TEXT
The Development of Social Anxiety in Adolescents With Autism Spectrum Disorders
Bellini
Focus Autism Other Dev Disabl 2006;21:138-145.
ABSTRACT
Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology
Baldwin et al.
J Psychopharmacol 2005;19:567-596.
ABSTRACT
Venlafaxine Extended Release vs Placebo and Paroxetine in Social Anxiety Disorder
Liebowitz et al.
Arch Gen Psychiatry 2005;62:190-198.
ABSTRACT
| FULL TEXT
Genome-Wide Linkage Scan for Loci Predisposing to Social Phobia: Evidence for a Chromosome 16 Risk Locus
Gelernter et al.
Am. J. Psychiatry 2004;161:59-66.
ABSTRACT
| FULL TEXT
Peripubertal Suicide Attempts in Offspring of Suicide Attempters With Siblings Concordant for Suicidal Behavior
Brent et al.
Am. J. Psychiatry 2003;160:1486-1493.
ABSTRACT
| FULL TEXT
Increased Amygdala Activation to Angry and Contemptuous Faces in Generalized Social Phobia
Stein et al.
Arch Gen Psychiatry 2002;59:1027-1034.
ABSTRACT
| FULL TEXT
Pindolol Potentiation of Paroxetine for Generalized Social Phobia: A Double-Blind, Placebo-Controlled, Crossover Study
Stein et al.
Am. J. Psychiatry 2001;158:1725-1727.
ABSTRACT
| FULL TEXT
|
